Combination Use of Tegafur and Apatinib as First-Line Therapy in Treatment of Advanced Gastric Cancer: A Single-Blinded Randomized Study

Table 2

Treatment efficacy and survival condition for all patients.

Variables, (%)	Combined group ()	Control group ()
CR	0 (0)	0 (0)	<0.001
PR	9 (29.0)	3 (9.7)
SD	19 (61.3)	18 (58.1)
PD	2 (6.5)	10 (32.0)
Response rate	9 (29.0)	3 (9.7)	<0.001
Disease control rate	29 (93.5)	21 (67.7)	<0.001

Note: CR: complete response; PR: partial response; SD: stable disease; and PD: progressive disease.